Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Astera Labs has received a consensus rating of "Moderate Buy" from 23 analysts, with 15 recommending a buy and 8 a hold.
• The average 1-year target price among brokerages for Astera Labs is $159.83, with Morgan Stanley and Deutsche Bank recently increasing their price targets to up to $215.00.
• In their latest quarterly earnings, Astera Labs reported $0.44 EPS, surpassing estimates, and a revenue increase of 149.5% year-over-year.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) has received an average recommendation of "Moderate Buy" from the twenty-three ratings firms that are covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $159.8333.

Several research firms recently commented on ALAB. Morgan Stanley lifted their price target on Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research report on Friday, August 29th. Cowen initiated coverage on shares of Astera Labs in a research note on Tuesday, September 30th. They issued a "hold" rating for the company. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research note on Tuesday, September 2nd. Evercore ISI raised their price objective on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. Finally, Stifel Nicolaus set a $145.00 price objective on shares of Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th.

Astera Labs Trading Up 1.3%

ALAB opened at $163.55 on Friday. The firm has a market cap of $27.19 billion, a P/E ratio of 292.05, a P/E/G ratio of 4.02 and a beta of 1.43. Astera Labs has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a 50-day moving average of $200.07 and a 200 day moving average of $127.18.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's revenue was up 149.5% on a year-over-year basis. During the same quarter last year, the business posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts forecast that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other news, COO Sanjay Gajendra sold 91,441 shares of Astera Labs stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief operating officer owned 2,170,877 shares of the company's stock, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jack R. Lazar sold 22,500 shares of Astera Labs stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the sale, the director directly owned 97,351 shares of the company's stock, valued at $17,369,365.42. This represents a 18.77% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,182,514 shares of company stock valued at $202,298,671. Insiders own 12.50% of the company's stock.

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently modified their holdings of the stock. Fred Alger Management LLC raised its stake in shares of Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock valued at $93,087,000 after acquiring an additional 179,638 shares in the last quarter. Hoey Investments Inc. raised its stake in shares of Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock valued at $553,000 after acquiring an additional 1,121 shares in the last quarter. Wealth Effects LLC bought a new stake in shares of Astera Labs during the second quarter valued at approximately $242,000. Maryland State Retirement & Pension System raised its stake in Astera Labs by 37.7% in the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company's stock worth $629,000 after buying an additional 1,906 shares in the last quarter. Finally, Realta Investment Advisors bought a new position in Astera Labs in the second quarter worth approximately $214,000. Institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.